Enoxaparin vs unfractionated heparin in acute coronary syndrome [2] (multiple letters)

JAMA

Volumn 292, Issue 16, 2004, Pages 1952-1953

  Pedrini, Michael ^a   Hartig, Frank ^a   Pechlaner, Christoph ^a   Kanna, Balavenkatesh ^b   Sharma, Puneeta ^b   Mahaffey, Kenneth W ^d   Ferguson, James J ^d   Califf, Robert M ^d   Blazing, Michael A ^c  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ENOXAPARIN; HEPARIN; FIBRINOLYTIC AGENT;

BLEEDING; DISEASE DURATION; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; HEART MUSCLE ISCHEMIA; LETTER; PRIORITY JOURNAL; ANGINA PECTORIS; HEART INFARCTION; HUMAN; NOTE;

ANGINA PECTORIS; ENOXAPARIN; FIBRINOLYTIC AGENTS; HEPARIN; HUMANS; MYOCARDIAL INFARCTION;

EID: 6944230921     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.292.16.1952-c     Document Type: Letter

References (0)